Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $374.47 | 41 | 58.6% |
| Unspecified | $150.00 | 1 | 23.5% |
| Education | $114.85 | 2 | 18.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $212.35 | 9 | $0 (2018) |
| Indivior Inc. | $150.00 | 1 | $0 (2020) |
| PFIZER INC. | $129.08 | 23 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $52.10 | 4 | $0 (2018) |
| CSL Behring | $21.93 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $18.33 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.90 | 1 | $0 (2019) |
| Allergan Inc. | $14.52 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $11.78 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $11.25 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $21.93 | 1 | CSL Behring ($21.93) |
| 2020 | $150.00 | 1 | Indivior Inc. ($150.00) |
| 2019 | $48.21 | 4 | PFIZER INC. ($22.06) |
| 2018 | $83.17 | 5 | Astellas Pharma US Inc ($54.50) |
| 2017 | $336.01 | 33 | Astellas Pharma US Inc ($157.85) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/25/2022 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 07/21/2020 | Indivior Inc. | BUPRENORPHINE AND NALOXONE (Drug), SUBOXONE | — | Cash or cash equivalent | $150.00 | Research |
| Study: Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior about SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) or the Authorized Generic of SUBOXONE Sublingual Film (CIII) Safety and Use Information • Category: OUD | ||||||
| 10/15/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/17/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/06/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: DIABETES | ||||||
| 08/09/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: DIABETES | ||||||
| 06/28/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: UROLOGY | ||||||
| 03/29/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: UROLOGY | ||||||
| 01/18/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: UROLOGY | ||||||
| 12/18/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 12/14/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: DIABETES | ||||||
| 12/11/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/01/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 11/20/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/09/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Urology | ||||||
| 11/06/2017 | HOSPIRA, INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $3.08 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/06/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 10/19/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Urology | ||||||
| 10/05/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $2.13 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/03/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/25/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/05/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior about SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) or the Authorized Generic of SUBOXONE Sublingual Film (CIII) Safety and Use Information | Indivior Inc. | $150.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 455 | 1,005 | $104,923 | $56,532 |
| 2022 | 11 | 520 | 1,036 | $114,721 | $70,298 |
| 2021 | 12 | 540 | 1,262 | $128,114 | $83,010 |
| 2020 | 14 | 668 | 1,467 | $143,807 | $91,310 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 169 | $25,330 | $14,584 | 57.6% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 74 | 257 | $26,985 | $14,042 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 201 | $22,095 | $11,320 | 51.2% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 62 | 178 | $14,018 | $5,627 | 40.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 26 | $8,060 | $5,462 | 67.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 31 | 31 | $2,635 | $2,274 | 86.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 42 | 49 | $4,116 | $1,860 | 45.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,286 | $971.85 | 75.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 60 | $398.50 | $390.53 | 98.0% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 78 | 252 | $28,980 | $17,571 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 242 | $25,265 | $15,217 | 60.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 163 | $22,570 | $13,762 | 61.0% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 66 | 116 | $18,550 | $11,099 | 59.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 17 | 20 | $6,200 | $4,295 | 69.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 33 | 33 | $2,507 | $2,235 | 89.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 39 | 50 | $4,200 | $1,922 | 45.8% |
| 99326 | New patient custodial care facility, group care, or assisted living visit, typically 45 minutes | Office | 2022 | 17 | 17 | $2,767 | $1,794 | 64.8% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 17 | 24 | $2,040 | $1,114 | 54.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 38 | 38 | $1,197 | $1,051 | 87.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 56 | 81 | $445.50 | $240.12 | 53.9% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 84 | 258 | $39,635 | $26,622 | 67.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 216 | $29,141 | $19,600 | 67.3% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2021 | 73 | 227 | $24,645 | $16,301 | 66.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 151 | $14,888 | $8,891 | 59.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 16 | 20 | $5,930 | $4,332 | 73.1% |
About Dr. Norman Frey, DO
Dr. Norman Frey, DO is a Geriatric Medicine healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487652012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Norman Frey, DO has received a total of $639.32 in payments from pharmaceutical and medical device companies, with $21.93 received in 2022. These payments were reported across 44 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($374.47).
As a Medicare-enrolled provider, Frey has provided services to 2,183 Medicare beneficiaries, totaling 4,770 services with total Medicare billing of $301,150. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Location Pittsburgh, PA
- Active Since 07/08/2005
- Last Updated 05/23/2023
- Taxonomy Code 207QG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487652012
Products in Payments
- BUPRENORPHINE AND NALOXONE (Drug) $150.00
- CHANTIX (Drug) $82.27
- Myrbetriq (Drug) $57.90
- VESICARE (Drug) $54.50
- TOUJEO (Drug) $28.67
- LYRICA (Drug) $27.46
- SOLIQUA (Drug) $23.43
- Kcentra (Biological) $21.93
- ANORO (Drug) $18.33
- VIAGRA (Drug) $15.33
- SPIRIVA RESPIMAT (Drug) $14.90
- VIBERZI (Drug) $14.52
- XARELTO (Drug) $11.78
- FARXIGA (Drug) $11.25
- ELIQUIS (Drug) $7.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Pittsburgh
Adele Towers
Geriatric Medicine — Payments: $63,447
John Haretos, M.d, M.D
Geriatric Medicine — Payments: $12,927
Sarah Shinn, Md, MD
Geriatric Medicine — Payments: $5,254
Namita Yende, Md, MD
Geriatric Medicine — Payments: $1,022
Umesh Golani
Geriatric Medicine — Payments: $772.69
Dr. Bernard Bernacki, D.o, D.O
Geriatric Medicine — Payments: $708.78